Literature DB >> 28262100

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Andrea Salonia1, Ganesh Adaikan2, Jacques Buvat3, Serge Carrier4, Amr El-Meliegy5, Kostas Hatzimouratidis6, Andrew McCullough7, Abraham Morgentaler8, Luiz Otavio Torres9, Mohit Khera10.   

Abstract

INTRODUCTION: Sexual dysfunction is common in patients after radical prostatectomy (RP) for prostate cancer. AIM: To provide the International Consultation for Sexual Medicine (ICSM) 2015 recommendations concerning management strategies for post-RP erectile function impairment and to analyze post-RP sexual dysfunction other than erectile dysfunction.
METHODS: A literature search was performed using Google and PubMed database for English-language original and review articles published up to August 2016. MAIN OUTCOME MEASURES: Levels of evidence (LEs) and grades of recommendations (GRs) are provided based on a thorough analysis of the literature and committee consensus.
RESULTS: Nine recommendations are provided by the ICSM 2015 committee on sexual rehabilitation after RP. Recommendation 6 states that the recovery of postoperative erectile function can take several years (LE = 2, GR = C). Recommendation 7 states there are conflicting data as to whether penile rehabilitation with phosphodiesterase type 5 inhibitors improves recovery of spontaneous erections (LE = 1, GR = A). Recommendation 8 states that the data are inadequate to support any specific regimen as optimal for penile rehabilitation (LE = 3, GR = C). Recommendation 9 states that men undergoing RP (any technique) are at risk of sexual changes other than erectile dysfunction, including decreased libido, changes in orgasm, anejaculation, Peyronie-like disease, and changes in penile size (LE = 2, GR = B).
CONCLUSION: This article discusses Recommendations 6 to 9 of the ICSM 2015 committee on sexual rehabilitation after RP. Salonia A, Adaikan G, Buvat J, et al. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med 2017;14:297-315.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Alprostadil; Climacturia; Erectile Dysfunction; Intracavernosal Injections; Orgasm; Peyronie Disease; Phosphodiesterase Type 5 Inhibitors; Prostate Cancer; Radical Prostatectomy; Rehabilitation; Sexual Desire

Mesh:

Year:  2017        PMID: 28262100     DOI: 10.1016/j.jsxm.2016.11.324

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  23 in total

Review 1.  Focusing on sexual rehabilitation besides penile rehabilitation following radical prostatectomy is important.

Authors:  Daphné Vanderhaeghe; Maarten Albersen; Emmanuel Weyne
Journal:  Int J Impot Res       Date:  2021-03-22       Impact factor: 2.896

2.  Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade.

Authors:  Paolo Capogrosso; Emily A Vertosick; Nicole E Benfante; James A Eastham; Peter J Scardino; Andrew J Vickers; John P Mulhall
Journal:  Eur Urol       Date:  2018-09-17       Impact factor: 20.096

Review 3.  Penile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy.

Authors:  George Coba; Trushar Patel
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

4.  Symptom and function profiles of men with localized prostate cancer.

Authors:  Bryce B Reeve; Xianming Tan; Ronald C Chen; Deborah S Usinger; Laura C Pinheiro
Journal:  Cancer       Date:  2018-04-16       Impact factor: 6.860

5.  Trends in reported male sexual dysfunction over the past decade: an evolving landscape.

Authors:  Edoardo Pozzi; Paolo Capogrosso; Luca Boeri; Walter Cazzaniga; Rayan Matloob; Eugenio Ventimiglia; Davide Oreggia; Nicolò Schifano; Luigi Candela; Costantino Abbate; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2020-07-01       Impact factor: 2.896

Review 6.  Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women's Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines.

Authors:  Na Tosha N Gatson; Maria L Boccia; Kerianne R Taylor; Jada K O Mack; Ekokobe Fonkem
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

Review 7.  Sexual function outcomes following interventions for prostate cancer: are contemporary reports on functional outcomes misleading?

Authors:  Catherine E Lovegrove; Vincenzo Ficarra; Francesco Montorsi; James N'Dow; Andrea Salonia; Suks Minhas
Journal:  Int J Impot Res       Date:  2019-12-13       Impact factor: 2.896

Review 8.  Neglected side effects to curative prostate cancer treatments.

Authors:  Alexander B Nolsøe; Christian Fuglesang S Jensen; Peter B Østergren; Mikkel Fode
Journal:  Int J Impot Res       Date:  2020-12-14       Impact factor: 2.896

Review 9.  Climacturia: a comprehensive review assessing pathophysiology, prevalence, impact, and treatment options regarding the "leak of pleasure".

Authors:  Ioannis Mykoniatis; Koenraad van Renterghem; Ioannis Sokolakis; Georgios Hatzichristodoulou; Maxime Sempels; Robert Andrianne
Journal:  Int J Impot Res       Date:  2020-03-17       Impact factor: 2.896

10.  Restoration of Cavernous Veno-Occlusive Function through Chronic Administration of a Jun-Amino Terminal Kinase Inhibitor and a LIM-Kinase 2 Inhibitor by Suppressing Cavernous Apoptosis and Fibrosis in a Rat Model of Cavernous Nerve Injury: A Comparison with a Phosphodiesterase Type 5 Inhibitor.

Authors:  Min Chul Cho; Junghoon Lee; Juhyun Park; Soo Woong Kim
Journal:  World J Mens Health       Date:  2020-07-09       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.